Further, we analyzed another dataset containing chromatin immunoprecipitation sequencing data previously presented by Gartlgruber et al. (15) of 47 resected neuroblastoma samples and found that MOXD1 expression was elevated in the MES and EMT group with previously unknown clinical and biological features (Fig. 2B). The gene discussed is MOXD1; the disease is neuroblastoma.